Caprock Group’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.04M | Sell |
19,976
-13,031
| -39% | -$782K | 0.03% | 532 |
|
|
2025
Q4 | $1.94M | Buy |
33,007
+1,705
| +5% | +$104K | 0.04% | 394 |
|
|
2025
Q3 | $1.71M | Buy |
+31,302
| New | +$1.68M | 0.04% | 400 |
|
|
2024
Q4 | – | Sell |
-12,622
| Closed | -$1.01M | – | 1046 |
|
|
2024
Q3 | $1.01M | Buy |
12,622
+217
| +2% | +$16.3K | 0.04% | 393 |
|
|
2024
Q2 | $889K | Buy |
12,405
+482
| +4% | +$35.5K | 0.04% | 397 |
|
|
2024
Q1 | $839K | Buy |
11,923
+30
| +0.3% | +$2.15K | 0.05% | 282 |
|
|
2023
Q4 | $918K | Sell |
11,893
-1,991
| -14% | -$131K | 0.06% | 253 |
|
|
2023
Q3 | $945K | Buy |
13,884
+275
| +2% | +$21.7K | 0.07% | 217 |
|
|
2023
Q2 | $1.11M | Buy |
13,609
+142
| +1% | +$11.4K | 0.08% | 197 |
|
|
2023
Q1 | $999K | Sell |
13,467
-484
| -3% | -$37.3K | 0.08% | 199 |
|
|
2022
Q4 | $1.16M | Buy |
13,951
+395
| +3% | +$31.4K | 0.11% | 144 |
|
|
2022
Q3 | $962K | Buy |
13,556
+132
| +1% | +$11.4K | 0.09% | 161 |
|
|
2022
Q2 | $1.16M | Sell |
13,424
-112
| -0.8% | -$10.5K | 0.11% | 137 |
|
|
2022
Q1 | $1.47M | Sell |
13,536
-72
| -0.5% | -$7.43K | 0.14% | 125 |
|
|
2021
Q4 | $1.76M | Buy |
13,608
+720
| +6% | +$88.3K | 0.15% | 105 |
|
|
2021
Q3 | $1.56M | Buy |
12,888
+92
| +0.7% | +$11.2K | 0.14% | 105 |
|
|
2021
Q2 | $1.44M | Hold |
12,796
| – | – | 0.13% | 120 |
|
|
2021
Q1 | $1.22M | Sell |
12,796
-12
| -0.1% | -$1.09K | 0.13% | 125 |
|
|
2020
Q4 | $1.02M | Buy |
12,808
+252
| +2% | +$18.3K | 0.12% | 139 |
|
|
2020
Q3 | $778K | Buy |
12,556
+156
| +1% | +$10.1K | 0.11% | 149 |
|
|
2020
Q2 | $819K | Hold |
12,400
| – | – | 0.12% | 138 |
|
|
2020
Q1 | $588K | Buy |
12,400
+20
| +0.2% | +$1K | 0.11% | 137 |
|
|
2019
Q4 | $679K | Hold |
12,380
| – | – | 0.12% | 131 |
|
|
2019
Q3 | $606K | Sell |
12,380
-200
| -2% | -$10K | 0.12% | 136 |
|
|
2019
Q2 | $656K | Hold |
12,580
| – | – | 0.13% | 132 |
|
|
2019
Q1 | $624K | Hold |
12,580
| – | – | 0.12% | 145 |
|
|
2018
Q4 | $455K | Hold |
12,580
| – | – | 0.1% | 166 |
|
|
2018
Q3 | $642K | Hold |
12,580
| – | – | 0.13% | 142 |
|
|
2018
Q2 | $465K | Hold |
12,580
| – | – | 0.1% | 188 |
|
|
2018
Q1 | $475K | Hold |
12,580
| – | – | 0.1% | 193 |
|
|
2017
Q4 | $440K | Buy |
12,580
+184
| +1% | +$5.85K | 0.09% | 218 |
|
|
2017
Q3 | $375K | Hold |
12,396
| – | – | 0.08% | 235 |
|
|
2017
Q2 | $364K | Buy |
+12,396
| New | +$339K | 0.08% | 235 |
|
|
2016
Q2 | – | Sell |
-12,396
| Closed | -$293K | – | 346 |
|
|
2016
Q1 | $293K | Buy |
+12,396
| New | +$273K | 0.07% | 231 |
|
|
2015
Q1 | – | Sell |
-12,396
| Closed | -$286K | – | 95 |
|
|
2014
Q4 | $286K | Buy |
+12,396
| New | +$284K | 0.31% | 67 |
|
Other funds holding TECH
VCM
VPM
MC
Caprock Group's TECH Position: Q1 2026 in Review
Caprock Group reduced its Bio-Techne (TECH) stake by 39% in Q1 2026, selling an estimated $782K and leaving 19,976 shares worth $1.04M. The position accounts for 0.03% of the portfolio, ranked #532.
Caprock Group first reported a position in TECH in Q4 2014 and has held it in 35 quarters since. The position peaked at $1.94M in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Caprock Group held 19,976 shares of Bio-Techne worth $1.04M as of Q1 2026.
- Caprock Group sold 13,031 Bio-Techne shares in Q1 2026, an estimated $782K.
- Bio-Techne made up 0.03% of Caprock Group's portfolio in Q1 2026, its #532 holding.
- Caprock Group first reported a position in Bio-Techne in Q4 2014 and has held it in 35 quarters since.
- Caprock Group's Bio-Techne position peaked at $1.94M in Q4 2025.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.